Led Ladder Bio's (formerly ThirdLaw Molecular) $5.5M seed financing and installed MEC Managing Partner Eric Heil as CEO.
Ladder Bio is a therapeutics company developing Spiroligomer™ ladder-shaped peptide-like molecules—sequence-defined, structurally preorganized molecules designed to be orally available, cell permeable, and engage challenging biological targets with high affinity and selectivity
Ladder Bio is a therapeutics company developing Spiroligomer™ ladder-shaped peptide-like molecules—sequence-defined, structurally preorganized molecules designed to be orally available, cell permeable, and engage challenging biological targets with high affinity and selectivity.